View the latest Linesight Global Country Commodity Reports for Q2 2023 and Industry Insights here

Close button
Share Linkedin icon Twitter icon Facebook icon Whatsapp icon

02 January 2024

Linesight's Michael Riordan features in Estates Gazette's 2024 UK Life Sciences Outlook

Michael Riordan, Managing Director at Linesight UK, recently shared his insights in Estate Gazette, alongside other industry leaders, on the evolving landscape of the UK Life Sciences sector for 2024. 

In this comprehensive discussion, Michael highlights the importance of developing new research districts beyond the established 'Golden Triangle' of London, Cambridge, and Oxford to meet the growing demands of the sector. 

He addresses the industry's challenges, including the need for ESG-compliant developments and overcoming infrastructure constraints. Michael also emphasizes the critical need for supporting the construction industry to scale up the production of specialized facilities and the importance of staff upskilling and recruitment to meet the sector's future demands. 

For a broader perspective on the UK Life Sciences market, including insights from various industry experts, read the full article here. 

About Linesight

Linesight is a multinational consultancy firm with over 49 years of experience, providingcost, schedule, program, and project management services to many sectors, including Life Sciences, Commercial, Data Centers, High-Tech Industrial, Residential, Hospitality, Healthcare, and Retail. Linesight's specialist project teams, each with specific skills and experience, provide faster project delivery, greater cost efficiency, and maximum value for money for our clients. 

Share

Related News